Literature DB >> 11504468

Mechanisms of fluoroquinolone resistance.

David C. Hooper1.   

Abstract

Mechanisms of bacterial resistance to fluoroquinolones fall into two principal categories, alterations in drug target enzymes and alterations that limit permeation of drug to the target, both resulting from chromosomal mutations. No specific resistance mechanisms of quinolone degradation or modification have been found. The target enzymes, DNA gyrase and topoisomerase IV are most commonly altered in domains near the enzyme active sites and in some cases reduced drug binding affinity has been demonstrated. Drug permeation is altered by mutations that increase expression of endogenous multidrug efflux pumps, alter outer membrane diffusion channels, or both. Recently a new plasmid-mediated resistance of an as yet undefined mechanism was found in clinical isolates of Klebsiella pneumoniae. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Year:  1999        PMID: 11504468     DOI: 10.1054/drup.1998.0068

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  131 in total

Review 1.  Mutation frequencies and antibiotic resistance.

Authors:  J L Martinez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance.

Authors:  D E Low; M Muller; C L Duncan; B M Willey; J C de Azavedo; A McGeer; B N Kreiswirth; S Pong-Porter; D J Bast
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 3.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

Authors:  Rodrigo Alonso; Marc Galimand; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Detection of qnr in clinical isolates of Escherichia coli from Korea.

Authors:  Jin-Yong Jeong; Hyun Jung Yoon; Eun Sil Kim; Yoola Lee; Sang-Ho Choi; Nam Joong Kim; Jun Hee Woo; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.

Authors:  Chi Hye Park; Ari Robicsek; George A Jacoby; Daniel Sahm; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

7.  Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes.

Authors:  Laszlo Otvos; Vanessa de Olivier Inacio; John D Wade; Predrag Cudic
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 8.  Development of novel antibacterial drugs to combat multiple resistant organisms.

Authors:  Matteo Bassetti; Elda Righi
Journal:  Langenbecks Arch Surg       Date:  2015-02-11       Impact factor: 3.445

9.  Emergence of antibiotic resistance from multinucleated bacterial filaments.

Authors:  Julia Bos; Qiucen Zhang; Saurabh Vyawahare; Elizabeth Rogers; Susan M Rosenberg; Robert H Austin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-09       Impact factor: 11.205

10.  DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.

Authors:  L M Weigel; G J Anderson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.